P2Y12 inhibitor-based single antiplatelet therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for P2Y12 inhibitor-based single antiplatelet therapy, covering 2026-01-30 to 2026-01-30. Get the full timeline:
Most recent: Clinical Trial Update: STEMI Treated With a Polymer-free Sirolimus-coated Stent and P2Y12 Inhibitor-based SAPT Versus Conventional DAPT [NA]